Safety and glycaemic control during exercise with the MiniMed™ 780G: A narrative review of evidence from lab to real world

Source
Diabetes, obesity & metabolism - ISSN 1462-8902- (2025) p.
Author(s)
    Jeremy Basset-Sagarminaga, Christophe de Block, Kirsten Norgaard, David Norman O'Neal, Tim van den Heuvel, Julie Taplin, Vittorino Smaniotto, Ohad Cohen

Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial

Source
The lancet : international edition - ISSN 0140-6736-406:10510 (2025) p.
Author(s)
    Chantal Mathieu, Julie Wych, A. Emile J. Hendriks, Lisa Van Ryckeghem, Timothy Tree, Piotr Chmura, Christopher Moller, Kristina Casteels, Thomas Danne, Felix Reschke, Darja Smigoc Schweiger, Tadej Battelino, Jesper Johannesen, Birgit Rami-Merhar, Thomas Pieber, Christophe de Block, Mark Evans, Robert Hilbrands, Emanuele Bosi, Ruben H. Willemsen, Supriyo Basu, Mari-Anne Pulkkinen, Mikael Knip, Miriam Cnop, Almut Nitsche, Anke M. Schulte, Elisabeth Niemoller, Mark Peakman, Charlotte Wilhelm-Benartzi, David Gillespie, Lut Overbergh, Adrian P. Mander, M. Loredana Marcovecchio

Diabetes risk perception in women with a recent history of gestational miabetes mellitus : a secondary analysis from a Belgian randomized controlled trial (MELINDA study)

Source
Journal of Clinical Medicine - ISSN 2077-0383-14:14 (2025) p. 1-21
Author(s)
    Yana Vanlaer, Caro Minschart, Ine Snauwaert, Nele Myngheer, Toon Maes, Christophe de Block, Inge Van Pottelbergh, Pascale Abrams, Wouter Vinck, Liesbeth Leuridan, Sabien Driessens, Jaak Billen, Christophe Matthys, Annick Bogaerts, Annouschka Laenen, Chantal Mathieu, Katrien Benhalima